Clin2
NCT07094672Likely a fitNot yet recruiting

Opioid withdrawal symptom study

Opioid Use Disorder

Part of Mental health clinical trials.

This study aims to better understand how people experience opioid withdrawal. You will be asked to describe your symptoms, which may help develop a new tool to measure withdrawal more accurately.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Had opioid use disorder in the past year (or are in treatment for it now)
  • Felt withdrawal symptoms at least once in the last month
  • Able to speak and understand English
  • Not pregnant or breastfeeding
  • No history of psychosis or mania, and no recent suicidal thoughts

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05027919Recruiting· Phase 2
Testing ways to predict opioid withdrawal during a taper

This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.

Baltimore, Maryland
NCT07128524Recruiting· Phase 2
Ketones for opioid craving study

This trial tests if a ketone supplement can help reduce cravings during opioid withdrawal treatment. Participants take the supplement daily and are monitored for changes in craving and withdrawal symptoms.

Wernersville, Pennsylvania
NCT06954402Recruiting
Resilience study for people with opioid use disorder

This study looks at resilience in people with opioid use disorder. Researchers want to understand what helps people stay strong and recover. You may be able to join if you are currently using opioids or receiving treatment.

Baltimore, Maryland
NCT05511909Recruiting· Phase 2
Buspirone study for opioid withdrawal symptoms

This Phase 2 study tests whether buspirone can help reduce symptoms during opioid detox (withdrawal). You may be able to take part if you have opioid withdrawal and are planning medically supervised detox.

Baltimore, Maryland
NCT06643988Recruiting
Memory and thinking study for opioid use disorder

This study looks at how people with opioid use disorder remember personal events. You'll do tasks on a cellphone and at home while taking medication for opioid use disorder.

Philadelphia, Pennsylvania
NCT06021548Recruiting
Opioid addiction markers study

This study looks at physical, psychological, and social factors that may be linked to opioid addiction. It aims to better understand addiction to help improve future treatments.

Bron

Hear when a new Opioid Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.